Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovum donation.

H I Abdalla1

  • 1Lister Hospital, London, UK.

Current Opinion in Obstetrics & Gynecology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Oocyte donation is a key infertility treatment, offering hope to many women. Recent studies show high pregnancy success rates in women over 40, indicating the endometrium

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome.

Human reproduction (Oxford, England)·2005
Same author

An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.

Human reproduction (Oxford, England)·2004
Same author

Does egg-sharing compromise the chance of donors or recipients achieving a live birth?

Human reproduction (Oxford, England)·2003
Same author

Swedish in-vitro fertilisation study.

Lancet (London, England)·2000
Same author

Embryo transfer: ultrasound-guided versus clinical touch.

Human reproduction (Oxford, England)·1999
Same author

A survey of anonymous oocyte donors: demographics.

Human reproduction (Oxford, England)·1998
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Area of Science:

  • Reproductive Medicine
  • Infertility Management
  • Assisted Reproductive Technologies

Background:

  • Oocyte donation is now a standard treatment for infertility.
  • It addresses various conditions including premature ovarian failure, failed IVF, and genetic disorders.
  • Advancements have expanded its application to older women.

Purpose of the Study:

  • To evaluate the efficacy of oocyte donation in women over 40.
  • To assess the role of endometrial receptivity in advanced maternal age.
  • To explore future directions in oocyte maturation and in vitro fertilization.

Main Methods:

  • Analysis of pregnancy rates in oocyte donation recipients.
  • Comparison of outcomes between women below and above 40 years of age.

Related Experiment Videos

  • Review of current and emerging techniques in assisted reproduction.
  • Main Results:

    • Pregnancy rates in women over 40 receiving oocyte donations are comparable to younger recipients.
    • This suggests that endometrial receptivity remains high despite advancing maternal age.
    • Encouraging results highlight the potential of oocyte donation for older women.

    Conclusions:

    • Oocyte donation is highly effective for infertility treatment, including in women over 40.
    • Endometrial function is preserved in older women, supporting successful implantation.
    • Future research focuses on in vitro maturation of immature oocytes for enhanced fertility treatments.